During his industry education session today at #ASHG25, CTO Steve Barnard shared further updates on how Illumina innovations are transforming insights as we lead the industry into a new era of omics. (1/6)

This is a very neat kit. 1000 cycles and the quality stays high at cross the whole read. Both reads! Illumina MiSeq i100

Going beyond the genome allows you to unlock deeper biology. Today at #ASHG25, Illumina’s Fiona Kaper shares our latest innovations across multiomics: real technologies, real impact, and a future of end-to-end solutions for researchers. (1/9)

Today in our 2nd Industry Education Session at #ASHG25, Sheila Dodge, Chief Operating Officer - Broad Clinical Labs, presented hot off the press early access data from a PerturbSeq experiment comprising >5 million cells processed in just 5 days, plug-and-play in their first

🧬 Register to watch the session on-demand here: bit.ly/4o7OHo1 (9/9) #ASHG25

Live at #ASHG25: Introducing BioInsight—Illumina’s newest business to help researchers and pharma unlock deeper insights from large‑scale multiomic data. Led by SVP & GM Rami Mehio, BioInsight unites Illumina’s strengths—sequencing, data analysis, software & AI. (1/7)

Beyond the sequencer, innovations like Illumina Protein Prep and Single Cell connect data across the omes with NGS-level precision, delivering insights that fuel discovery. Learn more about how Illumina is leading the way in multiomics from Cande Rogert, VP, Global Head of

Reads just got longer on the Illumina MiSeq i100 Series, and you’re still getting results in 24 hours. Introducing the first 1000 cycle kit – helping researchers drive breakthroughs faster on our most accessible platform. ✅ Full coverage of rearranged V(D)J receptors

“It never really has been a question whether we should get the new Illumina sequencer. We have to get the new Illumina sequencer.”​ See how Illumina NovaSeq X Plus is helping Genome Quebec power new breakthroughs with new multiomic capabilities, every day:

In the words of Illumina CTO Steve Barnard, "Go big and go ome." With the launch of our 5-base solution, a roadmap of multiomics capabilities, and our groundbreaking constellation mapped read technology, here's how Illumina is ushering in a new era of omics.

Innovation was everywhere at #ASHG25. From epigenomics to transcriptomics, Illumina put the future of multiomics in focus. Step inside the Illumina booth with Richard Capper, Sr Director, Global Research Customer Marketing, and explore a new layer of multiomic discovery. 👇

Headed to #AMPath2025 in Boston, November 11-15? 👋​ Visit booth 719 to see how we're helping labs unlock the full potential of genomics. Explore live demos, join Illumina-sponsored talks, and connect with our experts to discuss the innovations shaping the future of molecular

The SAMRC and DEPARTMENT OF SCIENCE,TECHNOLOGY & INNOVATION have signed an MoU with Illumina, in a landmark effort to sequence 110 000 genomes, building the country’s first comprehensive national genomic reference database. More on this: samrc.ac.za/press-releases…

In Q3, we brought our mission to life across multiomics, oncology, and data-driven discovery — strengthening our leadership in precision medicine. 1️⃣ Accelerating proteomics at scale We launched Illumina Protein Prep, expanding next-generation proteomics to researchers

We’ll be at #HUPO2025 talking about how Illumina Protein Prep helps labs of all sizes uncover the deepest biologic insights. Join Fiona Kaper, VP, Head of Assay R&D at Illumina, and Professor Stuart Cordwell, PhD, Academic Director of Sydney Mass Spectrometry at The University

Early results of Illumina® Protein Prep show measurable impact:​ ✔️ Genomics England: increased diagnostic yield for rare disease by 7.5%​ ✔️ PRECISE-SG100K (Singapore): expanded proteomic profiling across populations​ ✔️ Sydney Mass Spectrometry: first wider Asia Pacific site

What an incredible week at #AMPath2025 as we partner to deliver a trusted genomic ecosystem from sample to report.​ Together with our collaborators and customers, we discussed:​ ✅ growing implementation of in-house CGP testing in the community oncology setting​ ✅ AI-driven DNA

Important findings out of University, Florida on security vulnerabilities in portable DNA sequencers from Oxford Nanopore. As #genomics moves beyond traditional labs and closer to patients, securing devices and protecting data must be non-negotiable. A secure-by-design ecosystem is essential

Can we solve a mystery—and find missing heritability insights with whole genome-sequencing?​ A new Nature study from Illumina and UQ News shows how WGS captures coding and non-coding rare variants—offering insights beyond whole exome sequencing and array-based imputed

This is the story of how a breakthrough in cancer treatment, powered by #genetictesting, uncovered an unexpected family bond—a sister never before known. Sandra Perez’s story is a testament to the life-changing potential of genomic insights and their unexpected gifts. When a